Rim Diab: Presenting Protein S Research as a Rebalancing Strategy at ISTH 2026
Rim Diab, Scientist-Postdoc Researcher, Research Assistant, shared a post on LinkedIn:
“Grateful for the opportunity to share our latest research at the International Society on Thrombosis and Haemostasis (ISTH) 2026.
I had the privilege of presenting our work on Protein S as a hemostatic rebalancing strategy in both Factor XI deficiency and von Willebrand disease. It was a valuable experience to discuss these projects with researchers and clinicians from around the world.
A heartfelt thank you to my supervisors, Anne Angelillo-Scherrer and Raja Prince, for their guidance, support, and encouragement throughout these projects. I am also grateful to all my colleagues and collaborators whose contributions made this work possible.
I feel very fortunate to be part of BLEEDnFIRE Therapeutics to contribute to the development of new therapeutic approaches for bleeding disorders.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe LippiÖ‰ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question